Category: Inflammatory bowel diseases

W.28 - Evaluation of Novel Antisense Oligonucleotides Targeting RorĪ³t for Treatment of Chronic Inflammatory Diseases

Wednesday, Jun 14
6:15 PM – 7:45 PM

Ksenija Schirduan

Dr.rer.nat.
Secarna Pharmaceuticals GmbH
Martinsried, Bavaria, Germany